Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for Prevention of PTSD
NCT02402114Withdrawn
- Sponsor
- Einstein Healthcare Network
- Start
- Feb 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hydrocortisone in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Einstein Healthcare Network. Primary endpoint: Positive PTSD screens at 6 weeks. Planned start Feb 2015; status: withdrawn.
02
Drugs
hydrocortisone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02402114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402114.